文献速递免疫规划妇幼与学校卫生传染病防控与疫情报告

轮状病毒疫苗接种后肠套叠风险:基于队列与病例对照研究的循证Meta分析

Risk of intussusception following rotavirus vaccination: An evidence based meta-analysis of cohort and case-control studies.
PubMed 文献 · Vaccine · 2017-06-22

该Meta分析汇总截至2017年5月的队列与病例对照研究,评估轮状病毒疫苗接种后肠套叠风险。6项队列研究涉及4506265剂次首剂,5项病例对照研究共9643名儿童。结果显示首剂接种后及所有剂次接种后肠套叠风险均升高,以首剂后最为明显。

要点

  • 队列数据显示首剂接种后7天内肠套叠风险升高(RR=3.71,95%CI 1.08-12.69)。
  • 病例对照数据显示首剂接种后肠套叠风险升高(OR=8.45,95%CI 4.08-17.50)。
  • 所有剂次合并后风险仍升高:队列RR=3.47(95%CI 1.23-9.78),病例对照OR=1.59(95%CI 1.11-2.27)。

核心结论

  • Meta分析结果表明轮状病毒疫苗与肠套叠风险升高相关,主要见于首剂接种后。

研究设计与样本

  • 研究类型为系统综述与Meta分析,检索MEDLINE、PubMed、EMBASE和Google Scholar截至2017年5月。
  • 纳入6项队列研究(涉及4506265剂次首剂)和5项病例对照研究(总样本9643名儿童)。
  • 纳入研究评估轮状病毒疫苗接种与随后发生肠套叠的关系,包括首剂后及所有剂次合并后。
  • 采用随机效应模型合并结果。

主要发现

  • 队列数据显示首剂接种后7天内肠套叠风险升高(RR=3.71,95%CI 1.08-12.69)。
  • 队列数据显示所有剂次接种后肠套叠风险升高(RR=3.47,95%CI 1.23-9.78)。
  • 病例对照数据显示首剂接种后肠套叠风险升高(OR=8.45,95%CI 4.08-17.50)。
  • 病例对照数据显示所有剂次接种后肠套叠风险升高(OR=1.59,95%CI 1.11-2.27)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: International post-licensure studies on rotavirus vaccines have identified an increased risk of intussusception in infants after administration. The first developed rotavirus vaccine (Rotashield (RRV-TV)) was suspended post-licensure in 1999 after an association with intussusception was found. The currently available second-generation rotavirus vaccines (Rotateq (RV5) and Rotarix (RV1)), are recommended as a routine vaccine by the World Health Organisation (WHO). Post-licensure studies of these vaccines have shown a smaller but temporal increased risk for developing intussusception. METHODS: A meta-analysis was performed to summarise available evidence and to give an overall risk of developing intussusception from case-control and cohort studies for all rotavirus vaccines that have been manufactured up to date. A search was conducted on MEDLINE, PubMed, EMBASE and Google Scholar up to May 2017. Eligible studies assessed the relationship between the rotavirus vaccine administration and subsequent development of intussusception both after receiving the first dose and after receiving all doses combined. Data was extracted on study characteristics, methods and outcomes. Results were pooled using the random-effect model. RESULTS: Six cohort studies involving 4506265 total first doses and five case-control studies involving a total sample of 9643 children were included in this analysis. The cohort data revealed that there was an associated increased risk of intussusception after the first 7days post first dose of the vaccine (RR:3.71, 95% CI:1.08-12.69) and after receiving all doses of the rotavirus vaccine (RR:3.47, 95% CI:1.23-9.78). Similarly, the case-control data found an increased risk of intussusception following the first dose (OR: 8.45, 95% CI: 4.08-17.50) and following all doses (OR: 1.59, 95% CI: 1.11-2.27). CONCLUSIONS: Findings of this meta-analysis suggest that the rotavirus vaccine is associated with an increased risk on the development of intussusception, principally seen after administration of the first dose of vaccine.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kassim P, Eslick GD. Risk of intussusception following rotavirus vaccination: An evidence based meta-analysis of cohort and case-control studies. Vaccine. 2017. PMID: 28648544. doi:10.1016/j.vaccine.2017.05.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。